| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $3,101,604 ) |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | D71TW012265 | Next generation training in HIV research: Immunity in the First 1000 days in mother-infant dyads (TIGRIS) | 000 | 1 | NIH | 3/18/2022 | $30,240 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 002 | 16 | NIH | 6/9/2022 | $371,179 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 002 | 16 | NIH | 6/9/2022 | $172,739 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | D71TW011921 | African Tuberculosis Bioinformatics Training Program | 000 | 2 | NIH | 3/3/2022 | $108,000 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | D43TW010547 | Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research | 000 | 6 | NIH | 3/18/2022 | $293,909 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | D43TW010547 | Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research | 001 | 6 | NIH | 3/31/2022 | $50,000 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | D43TW010547 | Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research | 001 | 6 | NIH | 3/31/2022 | -$50,000 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI136836 | Inhibitors of CoA biosynthesis as novel antitubercular and antistaphylococcal agents | 000 | 5 | NIH | 2/25/2022 | $127,215 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI136894 | Pre- and post-treatment lung microbiota, metabolome and immune signatures at the site of disease in patients with active pulmonary tuberculosis | 000 | 4 | NIH | 5/20/2022 | $130,896 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW011006 | Interdisciplinary and multi-level approach to estimate the disease burden and outcomes of childhood tuberculous meningitis. | 000 | 3 | NIH | 1/10/2022 | $109,032 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI152109 | Nanoparticle-based host-directed therapies for eradication of Mycobacterium tuberculosis | 000 | 3 | NIH | 4/25/2022 | $135,784 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI152109 | Nanoparticle-based host-directed therapies for eradication of Mycobacterium tuberculosis | 000 | 3 | NIH | 4/25/2022 | $192,387 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01HD102050 | MECHANISMS LEADING TO ADVERSE BIRTH OUTCOMES IN SOUTH AFRICAN HIV-INFECTED WOMEN | 000 | 3 | NIH | 5/19/2022 | $142,138 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01HD102050 | MECHANISMS LEADING TO ADVERSE BIRTH OUTCOMES IN SOUTH AFRICAN HIV-INFECTED WOMEN | 000 | 3 | NIH | 5/19/2022 | $192,287 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R21TW012185 | Study of Metformin to reduce Cerebrovascular Dysfunction in South African patients with HIV and Metabolic Syndrome: A Phase II Pilot Trial. SMART | 002 | 2 | NIH | 6/8/2022 | $145,800 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 000 | 16 | NIH | 11/19/2021 | $270,182 |
| | 2022 | 2022 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 000 | 16 | NIH | 11/19/2021 | $580,562 |
| | 2022 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R61HD103093 | CHERISH (Children HIV Exposed Uninfected Research to Inform Survival and Health) | 000 | 2 | NIH | 5/9/2022 | $0 |
| | 2022 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | U01MH127704 | Research for Ethical Data Science in Southern Africa (REDSSA) | 000 | 1 | NIH | 5/19/2022 | $0 |
| | 2022 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R21TW012185 | Study of Metformin to reduce Cerebrovascular Dysfunction in South African patients with HIV and Metabolic Syndrome: A Phase II Pilot Trial. SMART | 000 | 1 | NIH | 10/22/2021 | $0 |
| | 2022 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R21TW012185 | Study of Metformin to reduce Cerebrovascular Dysfunction in South African patients with HIV and Metabolic Syndrome: A Phase II Pilot Trial. SMART | 001 | 1 | NIH | 2/18/2022 | $0 |
| | 2022 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | U01AI152075 | Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb) | 000 | 2 | NIH | 2/8/2022 | $0 |
| | 2022 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 001 | 15 | NIH | 6/6/2022 | $99,254 |
| | 2022 | 2020 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW010682 | Developing a care bundle for neonatal sepsis prevention in low-resource settings | 000 | 4 | NIH | 4/25/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $5,251,403 ) (Continued on the next page) |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R21TW012185 | Study of Metformin to reduce Cerebrovascular Dysfunction in South African patients with HIV and Metabolic Syndrome: A Phase II Pilot Trial. SMART | 000 | 1 | NIH | 8/6/2021 | $156,536 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 000 | 15 | NIH | 11/18/2020 | $500,871 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 000 | 15 | NIH | 11/18/2020 | $49,239 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 002 | 15 | NIH | 6/22/2021 | $500,869 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 002 | 15 | NIH | 6/22/2021 | $49,239 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | D71TW011921 | African Tuberculosis Bioinformatics Training Program | 000 | 1 | NIH | 8/4/2021 | $108,000 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW011028 | The long-term consequences of pulmonary tuberculosis and respiratory viruses on lung health in young South African children | 003 | 2 | NIH | 8/3/2021 | -$81,000 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW011028 | The long-term consequences of pulmonary tuberculosis and respiratory viruses on lung health in young South African children | 003 | 2 | NIH | 8/3/2021 | $81,000 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW011028 | The long-term consequences of pulmonary tuberculosis and respiratory viruses on lung health in young South African children | 002 | 2 | NIH | 8/2/2021 | -$113,385 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW011028 | The long-term consequences of pulmonary tuberculosis and respiratory viruses on lung health in young South African children | 002 | 2 | NIH | 8/2/2021 | $113,385 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW011028 | The long-term consequences of pulmonary tuberculosis and respiratory viruses on lung health in young South African children | 001 | 2 | NIH | 7/22/2021 | $81,000 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW011028 | The long-term consequences of pulmonary tuberculosis and respiratory viruses on lung health in young South African children | 000 | 2 | NIH | 7/7/2021 | $113,385 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | D43TW010547 | Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research | 000 | 5 | NIH | 6/16/2021 | $302,400 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | D43TW010547 | Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research | 001 | 5 | NIH | 8/17/2021 | $75,089 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW010683 | The effect of hypertensive disorders in pregnancy and HIV-infection on maternal, birth and infant outcomes in South Africa | 000 | 5 | NIH | 2/26/2021 | $113,397 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW010683 | The effect of hypertensive disorders in pregnancy and HIV-infection on maternal, birth and infant outcomes in South Africa | 002 | 5 | NIH | 7/21/2021 | $81,000 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW010683 | The effect of hypertensive disorders in pregnancy and HIV-infection on maternal, birth and infant outcomes in South Africa | 001 | 5 | NIH | 7/21/2021 | $0 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW010683 | The effect of hypertensive disorders in pregnancy and HIV-infection on maternal, birth and infant outcomes in South Africa | 003 | 5 | NIH | 8/18/2021 | $81,000 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | D43TW010511 | Advancing Research Ethics Training in Southern Africa (ARESA): Leadership Program | 000 | 5 | NIH | 6/4/2021 | $248,400 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW010683 | The effect of hypertensive disorders in pregnancy and HIV-infection on maternal, birth and infant outcomes in South Africa | 003 | 5 | NIH | 8/18/2021 | -$81,000 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI136836 | Inhibitors of CoA biosynthesis as novel antitubercular and antistaphylococcal agents | 000 | 4 | NIH | 2/10/2021 | $130,987 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI136894 | Pre- and post-treatment lung microbiota, metabolome and immune signatures at the site of disease in patients with active pulmonary tuberculosis | 000 | 3 | NIH | 7/6/2021 | $133,481 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW011006 | Interdisciplinary and multi-level approach to estimate the disease burden and outcomes of childhood tuberculous meningitis. | 000 | 2 | NIH | 1/4/2021 | $104,695 |
| | 2021 | 2021 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW011006 | Interdisciplinary and multi-level approach to estimate the disease burden and outcomes of childhood tuberculous meningitis. | 002 | 2 | NIH | 7/22/2021 | $80,855 |
|
